Manage episode 299854748 series 2738732
Episode 10 features Lars Wilde, co-founder and Chief Business Officer of Compass Pathways, a mental health company with an initial focus on psilocybin therapy for Treatment-Resistant Depression.
In this episode, we discuss:
- Lars’ experience overcoming Treatment-Resistant Depression with psilocybin
- The nuances of clinical trials and psilocybin dosing protocols
- Compass Pathways’ Intellectual Property strategy
- What additional indications and therapies Compass Pathways is interested in
Links to topics discussed in this episode:
Compass Pathways, Lars Wilde
Christian Angermayer, Robin Carhart-Harris, Michael Pollan
TRD (Therapy-Resistant Depression)
Compass Phase 2B Trial
Compass Pathways 2 US patents
Oregon Psilocybin Therapy Measure 109
Read the transcript here.
Watch episode 10 on YouTube.
Theme music by Dorian Love
Additional music: River Meditation by Jason Shaw and Thea by Muted Circus